Track the NeuroBo Pharmaceuticals, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 20 September 2024 (Cession). Among the most active insiders: DONG-A ST CO., LTD. The full history is free.
22
Insider Decl.
n/a
Thresholds
€17m
2 ops.
Buy Volume
€1,378
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate NeuroBo Pharmaceuticals, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
30Σ signal
Buys €17m€1,378 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.